from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0082/-

LFCtreatmentdescriptionclass of inhibitor

-0.610

Amikacinug/mL Amikacintranslation

-0.949

Cap5-10ug/mL Capreomycintranslation

-0.884

Rox10-50 ug/mL Roxithromycintranslation

-0.937

SM2-5 ug/mL Streptomycintranslation

-0.154

Tet5-10 ug/mL Tetracyclinetranslation

0.433

Rif0.2-5ug/mL Rifampicintranscription

-0.343

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.876

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.339

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.165

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.209

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.726

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.315

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.651

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.397

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-1.153

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.299

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.193

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.059

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.201

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-2.473

KCN5-20 ug/mL Potassium cyaniderespiration

-0.057

NaN30.2-2 mM Sodium aziderespiration

-1.058

Nigericin50 uM Nigericinrespiration

0.357

TRC10-150 ug/mL Triclosanrespiration

-0.571

TRZ10-25 ug/mL Thioridazinerespiration

-0.268

Valinomycin0.5-10 uM Valinomycinrespiration

-1.527

ZnSO42 mM ZnSO4respiration

0.120

menadione6-10 ug/mL Menadionerespiration

-0.122

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.512

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.388

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.625

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.740

NRP_1Non-replicating persistence stage 1dosRassociated

-0.360

Amp0.2mg/mL AmpicillincellWall

-0.560

Cephalexin20-100 ug/mL CephalexincellWall

-0.306

Cerulenin0.32-5 ug/mL CerulenincellWall

0.612

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.030

EMB10-20 ug/mL EthambutolcellWall

-1.416

Eta12-40 ug/mL EthionamidecellWall

-1.458

INH0.2-0.4 ug/mL IsoniazidcellWall

0.188

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.342

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.398

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.135

BZA0.12 mg/mL BenzamidearomaticAmides

0.644

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.124

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.837

H2O24 mM hydrogen peroxideDNAdamaging

-0.225

Levo10 ug/mL LevofloxacinDNAdamaging

0.661

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.267

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.460

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.704

UVUV-irradiationDNAdamaging

-0.865

ARP41-4 ug/mL Antitubercular compound ARP4?

0.397

Antimycin12.5-50 ug/mL Antimycin A?

-0.036

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.509

PA_110-50 ug/mL Antitubercular compound PA-1?

0.131

PA_2110-50 ug/mL Antitubercular compound PA-21?

-2.172

PA8240.2-2 ug/mL PA-824?

0.980

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.450

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.963

Verapamil50 uM Verapamil?

-0.684

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.385

methoxatin10-20 ug/mL Methoxatin?